Mycobacterium lentiflavum, an emerging pathogen?

Journal of Infection

Volumn 52, Issue 6, 2006, Pages

  Tortoli, Enrico ^a   Mattei, Romano ^b   Russo, Cristina ^c   Scarparo, Claudio ^d  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b CAMPO DI MARTE HOSPITAL   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Case report; Lymphadenitis; Mycobacterium lentiflavum; Pleurisy

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; BACTERIAL DNA; CEFTRIAXONE; CLARITHROMYCIN; DNA 16S; LEVOFLOXACIN; RIFABUTIN;

ABSCESS DRAINAGE; ACID FAST BACTERIUM; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPHADENITIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM LENTIFLAVUM; NONHUMAN; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PUS; THORAX RADIOGRAPHY;

ADOLESCENT; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES, EMERGING; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LEUKEMIA; LYMPHADENITIS; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PLEURA; PLEURAL EFFUSION; TREATMENT OUTCOME;

EID: 33744531052     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.08.020     Document Type: Article

References (15)

1. Springer B., Wu W.K., Bodmer T., and Haase G.P. Isolation and characterization of an unique group of slowly growing mycobacteria: Description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol 34 (1996) 1100-1107
2. Idigoras P., Beristain X., and Jimenez-Pajares Mf M.S. Aislamiento de Mycobacterium lentiflavum sin valor clinico en 30 pacientes. Enferm Infecc Microbiol Clin 22 (2004) 199-200
3. Tortoli E., Bartoloni A., Erba M.L., Levré E., Lombardi N., Mantella A., et al. Human infections due to Mycobacterium lentiflavum. J Clin Microbiol 40 (2002) 728-729
4. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: The new mycobacteria of the 1990s. Clin Microbiol Rev 16 (2003) 319-354
5. Ngo Niobe S., Bebear C.M., Clerc M., Pellegrin J.L., Bebear C., and Maugein J. Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient. J Clin Microbiol 39 (2001) 2030-2032
6. Galarraga M.C., Torreblanca A., and Jimenez M.S. Aislamiento de Mycobacterium lentiflavum en un caso sospechoso de cancer de pulmon. Enferm Infecc Microbiol Clin 20 (2002) 93-94
7. Ibàñez R., Serrano-Heranz R., Jiménez-Palop M., Román C., Corteguera M., and Jiménez S. Disseminated infection caused by slow-growing Mycobacterium lentiflavum. Eur J Clin Microbiol Infect Dis 21 (2002) 691-692
8. Piersimoni C., Goteri G., Nista D., Mariottini A., Mazzarelli G., and Bornigia S. Mycobacterium lentiflavum as an emerging causative agent of cervical lymphadenitis. J Clin Microbiol 42 (2004) 3894-3897
9. Tortoli E. Clinical features of infections caused by new nontuberculous mycobacteria. Part. I. Clin Microbiol Newsl 26 (2004) 89-95
10. Molteni C., Gazzola L., Cesari M., Lombardi A., Salerno F., Tortoli E., et al. Mycobacterium lentiflavum infection in immunocompetent patient. Emerg Infect Dis 11 (2005) 119-122
11. Cabria F., Torres M.V., Garcia-Cia J.I., Dominguez-Garrido M.N., Esteban J., and Jimenez M.S. Cervical lymphadenitis caused by Mycobacterium lentiflavum. Pediatr Infect Dis J 21 (2002) 574-575
12. Haase G., Kentrup H., Skopnik H., Springer B., and Böttger E.C. Mycobacterium lentiflavum: An etiologic agent of cervical lymphadenitis. Clin Infect Dis 25 (1997) 1245-1246
13. Uria M.J., Garcia J., Menendez J.J., and Jimenez M.S. Infeccion por Mycobacterium lentiflavum: A proposito de un caso y revision de la literatura medica. Enferm Infecc Microbiol Clin 21 (2003) 274-275
14. American Thorac Society. Diagnosis treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156 (1997) S1-S25
15. Ehlers S., and Richter E. Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vitro. Clin Exp Immunol 124 (2001) 229-238